Banner Before Header

Amplifyer Partners With Digital Ad Measurement Tool

0 356

Amplifyer is adding Mint Measure to its ad tech suite to provide a cost-efficient alternative to multi-touch attribution using a new-to-market deterministic approach

Amplifyer, the company that connects Fortune 1000 advertisers to the most innovative start-ups in the world, announced  that it has partnered with Mint Measure to provide marketers with a better understanding of their media delivery. Serving as a cost-effective alternative to leading multi-touch attribution vendors, Mint Measure provides new-to-market actionable insights, such as Unique Reach (uCPM), to allow advertisers to make more efficient media allocations and optimizations. Additional metrics include: deduplicated reach and frequency, vendor overlap comparison and conversion efficiency index.

Marketing Technology News: VOXOX Launches The Comeback Small Business Radio Show

“I’ve spent my career as a performance marketer and was frustrated by the lack of optimization tools from ad servers. Multi-touch attribution tools are so expensive, they rarely justified the cost for my clients,” said Scott Konopasek, Mint Measure’s CEO and Founder. “I am excited to be partnering with Amplifyer to bring Mint Measure to the brands that could really benefit from a cost-effective and deterministic measurement tool.” An ad agency veteran, Konopasek has managed the digital campaigns of leading companies like Slack and Bumble with a proven record of developing and implementing ROI-driven media strategies.

Marketing Technology News: Qualtrics and Korn Ferry Announce Significant Expansion of Strategic Partnership

“Mint Measure is an ideal complement to Amplifyer’s industry-leading ad tech suite. We believe in Scott’s forward-thinking vision of measurement in the digital ad space,” said Mike Aronow, CEO and Founder of Amplifyer. “The time is right for innovation that makes sophisticated analysis accessible to everyone.”

Marketing Technology News: Sage X3 V2020 R2 Released in India to Enable Indian Pharma Companies

Leave A Reply

Your email address will not be published.